MedPath

MESNEX

These highlights do not include all the information needed to use safely and effectively. See full prescribing information for . Initial U.S. Approval: 1988

Approved
Approval ID

2e8eebc3-ea75-4c57-bfe1-2c5dc2c37806

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 24, 2018

Manufacturers
FDA

Baxter Healthcare Corporation

DUNS: 005083209

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

MESNA

PRODUCT DETAILS

NDC Product Code0338-1307
Application NumberNDA019884
Marketing CategoryC73594
Route of AdministrationINTRAVENOUS
Effective DateJuly 24, 2018
Generic NameMESNA

INGREDIENTS (4)

MESNAActive
Quantity: 100 mg in 1 mL
Code: NR7O1405Q9
Classification: ACTIB
BENZYL ALCOHOLInactive
Quantity: 1.04 mg in 1 mL
Code: LKG8494WBH
Classification: IACT
EDETATE DISODIUMInactive
Quantity: 0.25 mg in 1 mL
Code: 7FLD91C86K
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MESNEX - FDA Drug Approval Details